Curcumin inhibits lymphangiogenesis in vitro and in vivo

Curcumin suppresses lymphatic vessel density in an in vivo human gastric cancer model

(2015) Wei Da et al.   TUMOR BIOLOGY

Abstract 2590: Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2.

(2014) Peter H. Killian et al.   CANCER RESEARCH

miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2

(2014) Emanuel Kronski et al.   Molecular Oncology

Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis

(2014) G. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

DAPK1 modulates a curcumin-induced G2/M arrest and apoptosis by regulating STAT3, NF-κB, and caspase-3 activation

(2013) Bingshan Wu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Curcumin glucuronides: Assessing the proliferative activity against human cell lines

(2013) Ashutosh Pal et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Curcumin-Targeting Pericellular Serine Protease Matriptase Role in Suppression of Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis

(2013) T.-S. Cheng et al.   Cancer Prevention Research

Comparison of the effects of curcumin and curcumin glucuronide in human hepatocellular carcinoma HepG2 cells

(2013) Motomu Shoji et al.   FOOD CHEMISTRY

Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis

(2013) Lei Liu et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Down-regulation of epidermal growth factor receptor by curcumin-induced UBE1L in human bronchial epithelial cells

(2013) A-Pei Jiang et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Serum Vascular Endothelial Growth Factor (VEGF-C) as a Diagnostic and Prognostic Marker in Patients with Ovarian Cancer

(2013) Daye Cheng et al.   PLoS One

Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis

(2013) G. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2

(2012) Peter H. Killian et al.   CARCINOGENESIS

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

(2012) George D Demetri et al.   LANCET

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

(2012) Axel Grothey et al.   LANCET

The Ubiquitin-Proteasome System Meets Angiogenesis

(2012) N. Rahimi   MOLECULAR CANCER THERAPEUTICS

Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia

(2011) R. E. Carroll et al.   Cancer Prevention Research

A Perspective on Cancer Cell Metastasis

(2011) C. L. Chaffer et al.   SCIENCE

Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer

(2010) Giridhar Mudduluru et al.   BIOSCIENCE REPORTS

Systemic Administration of Polymeric Nanoparticle-Encapsulated Curcumin (NanoCurc) Blocks Tumor Growth and Metastases in Preclinical Models of Pancreatic Cancer

(2010) Savita Bisht et al.   MOLECULAR CANCER THERAPEUTICS

Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects

(2008) S. K. Vareed et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Curcumin Inhibits Lung Cancer Cell Invasion and Metastasis through the Tumor Suppressor HLJ1

(2008) H.-W. Chen et al.   CANCER RESEARCH

Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

(2008) N. Dhillon et al.   CLINICAL CANCER RESEARCH

Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis

(2008) Shenhong Wu et al.   LANCET ONCOLOGY